Search

Baxter Healthcare is a leading manufacturer of speciality IV Solutions and Delivery Systems that help physicians, pharmacists and nurses safely administer critical fluids and medications to patients. The company first produced IV solutions in Australia in 1963 and since then has provided over 1 billion units of specialty IV and Irrigation solutions as well as Ready-To-Use medications to the Australian and New Zealand market. Today Baxter remains the only local manufacturer of IV Fluids.

The terms of use of this website ("Terms of Use") include all of the terms and conditions below and all other terms and conditions on this website. Please read and review these Ter

Baxter has been assisting clinicians in treating patients’ diverse clinical nutrition needs since the 1940s, when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance intravenous (IV) nutrition by offering essential components of parenteral nutrition therapy in sterile, triple-chamber containers.

Baxter has a long history in the supply of aseptically compounded medications to patients across Australia and New Zealand. Baxter operates eight TGA / Medsafe accredited compounding centres that employ over 450 pharmacists, technicians and operations staff. All of our Pharmacy Services staff are trained to the same exacting set of standards and procedures and we are proud to consistently achieve industry-leading quality and service levels. Baxter provides an individual service tailored to meet your specific needs, delivering a total solution for all of your aseptic antibiotic compounding requirements. Our product range includes; Chemotherapy & Monoclonal Antibody Compounding, Antibody Compounding, Analgesics and Critical Care and Baxter Infusors

Baxter is focused on providing renal patients the best possible life by elevating the standards of care across all therapeutic options, whether that be in-center or home for chronic care, or in a hospital setting for acute care. Baxter is committed to addressing the individual needs of patients by supporting greater access to innovative renal care products, therapies, services and support globally.

A deep understanding of large proteins and biologics development is at the heart of our work to create hemostatic agents and sealants used during surgery. Baxter offers biological and synthetic products used to stop bleeding and seal wounds in surgery. Baxter technologies also are used to facilitate hard tissue regeneration in orthobiologics and soft tissue repair in a variety of surgical procedures. We are proud to be helping improve clinical outcomes for patients through our range of products.

Registered users of Baxter Professional have 24/7 access to our online learning modules as well as comprehensive research tools provided by EBSCO.